Journal of the National Cancer Institute Advance Access originally published online on May 27, 2008
JNCI Journal of the National Cancer Institute 2008 100(11):827-828; doi:10.1093/jnci/djn042
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press 2008.
CORRESPONDENCE |
Response: Re: Prospective Study of Vitamin D and Cancer Mortality in the United States
Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DMF, BIG); National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (ACL); AstraZeneca International, Wilmington, DE, formerly with Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (SCC)
Correspondence to: D. Michal Freedman, PhD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, EPS Rm 7036, 6120 Executive Blvd, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-7238 (e-mail: mf101e@nih.gov).
| The first 10% of the full text of this article appears below. |
We appreciate the opportunity to address comments by Garland et al. and Grant regarding our recent publication on vitamin D and cancer mortality. Garland et al. contend that we should have highlighted
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 826.
J Natl Cancer Inst 2008 100: 826-827.